Fig. 2: Graft-versus-host disease (GVHD)-based endpoints according to GVHD prophylaxis.

a Acute GVHD Grade II–IV; b Acute GVHD Grade III-IV; c Chronic GVHD; d Extensive chronic GVHD; e Grade III-IV acute GVHD or severe chronic GVHD, relapse-free survival (GRFS).